Previous 10 | Next 10 |
home / stock / onc:cc / onc:cc news
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights PR Newswire Pelareorep advancing to a registration-enabling study in 2024 in pancreatic cancer and expands pancreatic potential with new GOBLET cohort in combination...
Taseko Mines Limited (TKO:CA) is expected to report $0.09 for Q4 2023 Purepoint Uranium Group Inc. (PTU:CA) is expected to report for quarter end 2023-12-31 Perpetual Energy Inc. (PMT:CA) is expected to report $-0.02 for Q4 2023 Park Lawn Corporation (PLC:CA) is expected to report $0....
2024-03-06 09:10:00 ET March 6, 2024 Investorideas.com , a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments for pancreatic cancer treatments, featuring Oncolytics Biotech Inc. ( NASDAQ: ONCY ) (TSX: ONC ), a clinical-stage i...
2024-03-06 08:40:19 ET Vancouver, Kelowna and Delta, British Columbia – March 6, 2024 – Investorideas.com , a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments for pancreatic cancer treatments, featuring Oncolytics Bi...
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - March 6, 2024) - Investorideas.com , a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments for pancreatic cancer treatments, featuring Oncolytics Biotech ® Inc. (NASDAQ: ON...
2024-03-05 08:30:57 ET Palm Beach, FL – March 5, 2024 – FN Media Group News Commentary – Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of t...
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN PR Newswire US$5M grant supports study of pelareorep in combination with modified FOLFIRINOX +/- atezolizumab Testing with the most common therapies co...
Canadian Critical Minerals Inc. (CCMI:CA) is expected to report for quarter end 2023-11-30 Ensign Energy Services Inc. (ESI:CA) is expected to report $0.03 for Q4 2023 Alphamin Resources Corp. (AFM:CA) is expected to report $0.02 for Q4 2023 Osisko Mining Inc. (OSK:CA) is expected to ...
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference PR Newswire SAN DIEGO and CALGARY, AB , Feb. 28, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ON...
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - February 15, 2024) - Investorideas.com , a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a clin...
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONC:CC Stock Symbol:
TSXC Market:
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial PR Newswire Anticipated evaluation to include combination therapy featuring treatment regimen of checkpoint inhibition and chemotherapy uti...
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire Pelareorep advancing to registration-enabling studies Preparations underway for Type C meeting with the FDA to establish registrational pathway in HR+/HER2- met...
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...